Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Coalition Against Major Diseases (CAMD) is a public-private partnership designed to creating new tools and methods that can be applied to increase the efficiency of the development process for new treatments for Alzheimer’s disease (AD) and related neurodegenerative diseases with impaired cognition and function. Professor Gallacher will present DPUK’s work ‘Deep Phenotyping of AD patients – Modelling Real World Evidence’ and will be part of the panel discussion on 'Global Synergies'.